Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Early Phase 1
1(50.0%)
2Total
N/A(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05811650Not ApplicableCompleted

School Oral Health Intervention in Nepal

Role: lead

NCT03816618Early Phase 1Completed

The Healing Effects Of Honey and Hydrogel Products On The Diabetic Foot

Role: lead

NCT03414957Completed

Malay Women With PCOS and Their Association With Metabolic Syndrome

Role: lead

All 3 trials loaded